Items tagged with Guidelines

Latent TB Infection: Updated and consolidated guidelines for programmatic management (post with simple image)

The World Health Organization issues new recommendations calling for accelerated uptake of testing and treatment for TB prevention.

New guide to shorter regimen for treating drug-resistant TB (post with simple image)

DR-TB STAT + TAG brief: Is Shorter Better? Understanding the Shorter Regimen For Treating Drug-Resistant Tuberculosis

WHO treatment guidelines for isoniazid-resistant TB (post with simple image)

The World Health Organization issues recommendations on management of isoniazid-resistant TB.

WHO response to STREAM Stage 1 preliminary results (post with simple image)

WHO issues a position statement on the continued use of the shorter MDR-TB regimen following an expedited review of the STREAM Stage 1 preliminary result.

Advocates call for urgent reforms of WHO TB diagnosis and treatment guidelines (post with simple image)

Advocates call on WHO leadership to ensure rapid development of clear, consolidated guidelines for the diagnosis and treatment of TB.

ECDC and EMCDDA make the case for active case finding of communicable diseases in prison (post with simple image)

The European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) release a common evidence-based guidance for the prevention and control of communicable diseases in prison settings in the EU/EEA.

South Africa makes bedaquiline part of its standard recommended treatment regimen for rifampicin-resistant TB (post with simple image)

Global TB CAB welcomes introduction of safer drug for most South Africans with rifampicin-resistant TB; Other countries and the World Health Organization must now follow.

Treatment Action Group welcomes price reductions for TB medicines (post with simple image)

Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.

WHO announces landmark changes in MDR-TB treatment regimens (post with simple image)

Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.

The TB CAB and TAG welcome WHO recommendation of injectable-free regimens for the treatment of RR/MDR-TB (post with simple image)

The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.

Page 7 of 7 · Total posts: 0

←First 6 7